← Back to Basal Cell Carcinoma

Advanced Basal Cell Carcinoma

When BCC is locally advanced or has spread

Medically reviewed by Dr. Steven Q. Wang, MDLast reviewed

Bring a printable list of questions to your appointment, or share this page with someone who needs it.

What Is Advanced Basal Cell Carcinoma?

Nearly all basal cell carcinomas (BCCs) are cured with a single office procedure. A small fraction behave differently — growing deep into surrounding tissue, coming back repeatedly after surgery or radiation, or, very rarely, spreading beyond the skin. Doctors call these tumors "advanced," and they are managed with a different set of tools, often by a team rather than a single dermatologist.

"Advanced BCC" is an umbrella term for two distinct situations:

Locally advanced BCC

The tumor has grown large or deep, invaded cartilage, bone, or nerves, or recurred after treatment — and surgery or radiation can no longer remove it without unacceptable damage to function or appearance. This accounts for the large majority of advanced cases.

Metastatic BCC

The cancer has spread to lymph nodes or distant organs such as the lungs or bone. This is one of the rarest events in oncology, occurring in well under 1% of all BCCs, but it is treated with the same systemic medications used for locally advanced disease.

Have Questions?

Ask questions and get clear, trusted answers — instantly.

Chat with the Navigator

Signs a BCC May Be Advanced

Most BCCs are small and slow-growing. Features that prompt a doctor to consider advanced disease include:

  • •A tumor that has come back one or more times after surgery or radiation
  • •A large growth (several centimeters) or one that is enlarging quickly
  • •A lesion fixed to deeper tissue, or that has destroyed cartilage or bone
  • •Numbness, tingling, weakness, or persistent pain near the tumor (possible nerve involvement)
  • •A tumor around the eye, nose, or ear where removal would threaten function or appearance
  • •A firm or swollen lymph node near a known skin cancer

Who Develops Advanced BCC

  • •People whose tumor went untreated or unnoticed for years
  • •Tumors with an aggressive subtype (morpheaform, infiltrative, basosquamous)
  • •BCCs that keep recurring in the same area despite treatment
  • •Weakened immune systems, including organ transplant recipients
  • •Gorlin syndrome (basal cell nevus syndrome), which causes many BCCs over a lifetime
  • •Prior radiation to the affected area

Why Timely Treatment Matters

Advanced BCC is largely preventable. Most cases follow years of an untreated tumor or one that recurred repeatedly without a change in approach.

A BCC caught and treated early is almost always cured with a single procedure. The same tumor left to grow can eventually require systemic medication, reconstruction, or a multidisciplinary team. If you have a BCC that has recurred or is changing, ask your dermatologist whether a referral is warranted.

Systemic Treatment Overview

When surgery and radiation are no longer options, advanced BCC is treated with medication that works throughout the body. Treatment is individualized, and every option below carries meaningful side effects that are weighed against its benefits.

  • •Hedgehog pathway inhibitors: Oral targeted drugs (vismodegib, sonidegib) that block the signaling pathway driving the growth of most BCCs. Usually the first systemic option for locally advanced or metastatic disease.
  • •Immunotherapy (PD-1 inhibitors): Cemiplimab helps the immune system attack the cancer and is an option when a hedgehog inhibitor stops working or cannot be tolerated.
  • •Radiation therapy: Can be the primary treatment for some inoperable tumors, or given after surgery to reduce the chance of recurrence.
  • •Clinical trials: New agents and drug combinations for advanced BCC are under active study and may be an option at any stage of treatment.

Sources

Clinical Guidelines & Peer-Reviewed Literature

  • Work Group; Bichakjian C, Armstrong A, Baum C, et al. Guidelines of care for the management of basal cell carcinoma. J Am Acad Dermatol. 2018;78(3):540-559. PubMed
  • Krakowski AC, Hafeez F, Westheim A, Pan EY, Wilson M. Advanced basal cell carcinoma: What dermatologists need to know about diagnosis. J Am Acad Dermatol. 2022;86(6S):S1-S13. PubMed

Patient Resources

Disclaimer: This page is for educational purposes only and is not a substitute for professional medical advice. Always consult a qualified dermatologist or oncologist about your diagnosis and treatment plan.

Printable Discussion Guide

Every question from the topics above, collected into one printable checklist — with a checkbox and space for notes beside each, and header fields for your appointment date and doctor's name.

Need More Information?

Chat with our AI guide for information about advanced basal cell carcinoma

Chat with the Navigator